Reports Q1 revenue $1.76M, consensus $1.75M. “We are driving strong market adoption of LungFit PH as we continue to break down barriers and expand our global distribution network,” said Steve Lisi, chairman and CEO. “This momentum in our business resulted in strong sequential revenue growth of approximately 50%, to $1.8 million compared with $1.2 million for the March 31, 2025 quarter. Looking ahead, we expect the trajectory of our sales to support sustained double-digit sequential revenue growth and reaffirm our FY 2026 revenue guidance of $12 to $16 million.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XAIR:
- Beyond Air (XAIR) Q1 Earnings Cheat Sheet
- Beyond Air’s Growth Potential Bolstered by Strategic Agreements and Financial Positioning
- Beyond Air awarded therapeutic gases agreement with Premier, Inc.
- Beyond Air initiated with a Buy at D. Boral Capital
- Upcoming Stock Splits This Week (July 14 to July 18) – Stay Invested